[Vasculitis assessment with [18F]FDG positron emission tomography]

Area of Science:

• Nuclear Medicine
• Radiology
• Immunology

Background:

• Large vessel vasculitis (LVV) requires accurate diagnostic tools for timely intervention.
• Noninvasive imaging is crucial for assessing disease activity and extent.
• [18F]fluorodeoxyglucose positron emission tomography (PET) is a metabolic imaging technique with potential in LVV assessment.

Purpose of the Study:

• To evaluate the utility of [18F]fluorodeoxyglucose PET in diagnosing and assessing large vessel vasculitis.
• To compare PET imaging with other modalities like MRI for early detection of vascular inflammation.
• To determine the specificity and sensitivity of PET in differentiating arteritis from atherosclerosis.

Main Methods:

• Utilized [18F]fluorodeoxyglucose PET imaging for metabolic assessment of vascular inflammation.
• Employed visual grading of vascular [18F]FDG uptake to differentiate arteritis from atherosclerosis.
• Considered scanning during active inflammatory phases and prior to corticosteroid treatment for optimal sensitivity.

Main Results:

• PET imaging demonstrated usefulness in diagnosing giant cell arteritis, Takayasu's arteritis, and unclassified aortitis.
• PET may be superior to MRI in detecting early-stage vascular wall inflammation.
• Visual grading of [18F]FDG uptake provides high specificity in discriminating arteritis from active atherosclerosis.

Conclusions:

• [18F]fluorodeoxyglucose PET is a valuable noninvasive tool for assessing large vessel vasculitis.
• PET imaging offers high specificity and potentially high sensitivity for LVV diagnosis.
• Further prospective studies are needed to establish PET's role in other vasculitis subsets and treatment monitoring.